Cambridge City Publishers
  • CB1 OBG, Cambridge City, UK
  • Submit Manuscript

Journal of Asthma Case Reports

Journal of Asthma Case Reports accepting case reports in Asthma journal, images in Asthma journal, case reports journal of Asthma and Allergy, Asthma case reports journal etc. Current drug therapy for asthma is very effective and has evolved from present substances through logical pharmaceutical developments. Pharmacology has played a critical role in asthma drug development and a number of other key experimental observations are published during this Journal of Asthma Case Reports. Understanding the pharmacology of effective drug therapies has also taught us much about the underlying mechanisms of asthma. Adrenoceptor agonists are the foremost effective bronchodilators and evolved from catecholamines from the medulla, whereas corticosteroids, from the cortex, are far and away the foremost effective controllers of the underlying inflammatory process in the airways. Cromoglycate, derived from a plant material and theophylline, a dietary methyl xanthine, have also been extensively utilized in the therapy of asthma, but we still don't understand their molecular mechanisms. It seems likely that pharmacology, instead of genetics, will remain the most approach to the further improvement of treatment for asthma. Pharmacology has played a crucial role in improving natural products to form effective long lasting and safe asthma therapies, but has thus far been challenged to supply new classes of antiasthma therapy. The only novel class of antiasthma therapy introduced within the last 30 years are leukotriene antagonists, which are less effective than existing treatments. New, more specific, therapies targeted at specific cytokines are less effective than corticosteroids, whereas more effective therapies carry a risk of side effects that may not be acceptable.

Manuscript Submission

Authors are requested to submit their manuscript by using Online Manuscript Submission Portal:

(or) also invited to submit through the Journal E-mail Id: